(Q36167258)

English

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Cytomegalovirus

0 references

systematic review

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Giovanni Strippoli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

6

object named as

Kathy Kable

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2

object named as

Cheryl A Jones

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Elisabeth M Hodson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Peter G Barclay

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Dushyanthi Vimalachandra

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

365

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2105-2115

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

9477

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964447%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV) prophylaxis by acyclovir in pre-transplant CMV-positive renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of prophylaxis of CMV disease in solid organ transplantation: is Ganciclovir a superior agent to Acyclovir?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus and death in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of mortality following heart transplantation: Spanish Registry of Heart Transplantation 1984-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report--2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966553-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36167258&oldid=1747681327"